Share Price and Basic Stock Data
Last Updated: January 29, 2026, 6:29 pm
| PEG Ratio | 0.31 |
|---|
Analyst Insight & Comprehensive Analysis
AI Stock Ranker – Real-Time Fundamental Strength Score
Business Overview and Revenue Trends
Kuantum Papers Ltd operates in the Paper & Paper Products sector, with a current market capitalization of ₹766 Cr and a share price of ₹88.6. The company reported a revenue of ₹1,310 Cr for the financial year ending March 2023, which marked a significant increase from ₹830 Cr in the previous year. However, revenues have shown a declining trend in subsequent quarters, with ₹1,211 Cr projected for March 2024 and ₹1,107 Cr for March 2025. Quarterly sales have also decreased from ₹350.60 Cr in December 2022 to ₹298.18 Cr in September 2023, indicating potential challenges in maintaining revenue growth amidst fluctuating demand. The operating profit margin (OPM) for the most recent quarter stood at 12.28%, down from a high of 34.99% in June 2023. These figures suggest that while the company has experienced robust historical growth, recent performance raises concerns about sustainability and market conditions.
Profitability and Efficiency Metrics
Kuantum Papers Ltd reported a net profit of ₹65 Cr for the financial year ending March 2023, translating to an earnings per share (EPS) of ₹7.45, reflecting a robust performance compared to the previous year. However, net profit has shown a declining trend, with projections of ₹33.89 Cr for March 2024 and ₹26.12 Cr for March 2025. The return on equity (ROE) stood at 10.1%, while the return on capital employed (ROCE) was recorded at 11.4%. The interest coverage ratio (ICR) was strong at 6.33x, indicating that the company can comfortably meet its interest obligations. Nevertheless, the cash conversion cycle (CCC) of 107 days highlights inefficiencies in working capital management. The declining OPM and net profit margin, which fell to 10.40% in March 2025 from 10.39% in March 2023, point to potential pressures on profitability due to rising costs or declining sales prices.
Balance Sheet Strength and Financial Ratios
The balance sheet of Kuantum Papers Ltd shows total assets of ₹2,113 Cr as of March 2025, with total borrowings amounting to ₹678 Cr, resulting in a debt-to-equity ratio of 0.53. The reserves stood at ₹1,196 Cr, providing a solid buffer against financial volatility. The company reported a book value per share of ₹138.97, which is favorable compared to its current price-to-book value (P/BV) ratio of 0.72x. This low P/BV ratio indicates that the stock is undervalued compared to its book value. The company’s current ratio is at 0.83, which is below the ideal benchmark of 1, suggesting potential liquidity issues. However, the inventory turnover ratio has improved to 9.26, reflecting efficient inventory management practices. The interest coverage ratio of 6.33x provides reassurance regarding the company’s ability to service its debt, although the recent decline in profitability metrics raises concerns about future financial stability.
Shareholding Pattern and Investor Confidence
Kuantum Papers Ltd has a stable shareholding pattern, with promoters holding a significant 70.31% stake, indicating strong management control and alignment with shareholder interests. The presence of foreign institutional investors (FIIs) has been minimal, with their stake recorded at 0.00% as of September 2025. Public shareholding accounted for 29.68%, with the number of shareholders rising to 22,729. This increase reflects growing interest among retail investors, although the absence of institutional backing may raise questions about liquidity and market confidence. The dividend payout ratio has fluctuated, with a reported payout of 23% for March 2025, which may attract income-focused investors. However, the lack of significant institutional investment could indicate a cautious approach from larger investors regarding the company’s future growth potential and financial health.
Outlook, Risks, and Final Insight
Looking ahead, Kuantum Papers Ltd faces several risks, including declining revenue trends and potential cost pressures that could further impact profitability. The company’s reliance on a single industry exposes it to cyclical downturns in the paper market, which could affect sales and operational efficiency. Additionally, the declining operating profit margins and increasing cash conversion cycle present challenges in maintaining financial health. However, the strong promoter backing and low P/BV ratio provide some comfort for investors. Should the company successfully navigate operational inefficiencies and stabilize its revenue streams, it could regain its growth trajectory. Conversely, any further decline in sales or profitability could lead to increased investor skepticism. Overall, while Kuantum Papers Ltd has a solid foundation, addressing these risks will be crucial for sustaining investor confidence and achieving long-term success.
Source: Getaka Fundamental Analysis | Generated using proprietary financial data.
Competitors
| Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
|---|---|---|---|---|---|---|---|---|---|
| Mohit Paper Mills Ltd | 37.4 Cr. | 26.8 | 38.8/25.4 | 5.87 | 39.0 | 0.00 % | 12.0 % | 13.6 % | 10.0 |
| Gratex Industries Ltd | 5.46 Cr. | 18.0 | 26.2/14.2 | 49.6 | 12.2 | 0.00 % | 3.85 % | 2.52 % | 10.0 |
| Ganga Papers India Ltd | 91.4 Cr. | 84.7 | 114/75.1 | 60.5 | 29.0 | 0.00 % | 6.44 % | 5.19 % | 10.0 |
| Encode Packaging India Ltd | 3.84 Cr. | 12.2 | 19.0/10.6 | 10.3 | 0.00 % | 2.06 % | 2.12 % | 10.0 | |
| Cella Space Ltd | 26.0 Cr. | 12.9 | 19.3/9.11 | 27.0 | 10.3 | 0.00 % | 10.7 % | % | 10.0 |
| Industry Average | 702.73 Cr | 71.79 | 43.19 | 107.44 | 0.77% | 9.32% | 134.80% | 6.50 |
Quarterly Result
| Metric | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 340.99 | 350.60 | 343.73 | 312.81 | 298.18 | 301.47 | 298.85 | 280.75 | 278.86 | 270.08 | 277.35 | 222.92 | 279.70 |
| Expenses | 241.66 | 245.58 | 229.71 | 203.35 | 217.57 | 222.10 | 235.24 | 209.18 | 218.11 | 219.69 | 217.47 | 182.52 | 245.36 |
| Operating Profit | 99.33 | 105.02 | 114.02 | 109.46 | 80.61 | 79.37 | 63.61 | 71.57 | 60.75 | 50.39 | 59.88 | 40.40 | 34.34 |
| OPM % | 29.13% | 29.95% | 33.17% | 34.99% | 27.03% | 26.33% | 21.28% | 25.49% | 21.79% | 18.66% | 21.59% | 18.12% | 12.28% |
| Other Income | 0.99 | 1.22 | 0.12 | 0.84 | 1.01 | 0.72 | 3.07 | 0.86 | 1.74 | 2.08 | 1.40 | 1.43 | 2.21 |
| Interest | 19.57 | 17.52 | 15.86 | 11.31 | 12.26 | 11.26 | 8.01 | 8.95 | 9.41 | 10.50 | 10.44 | 10.39 | 11.90 |
| Depreciation | 11.28 | 11.40 | 11.50 | 11.72 | 11.93 | 12.35 | 12.26 | 12.52 | 13.00 | 13.81 | 14.66 | 15.20 | 16.30 |
| Profit before tax | 69.47 | 77.32 | 86.78 | 87.27 | 57.43 | 56.48 | 46.41 | 50.96 | 40.08 | 28.16 | 36.18 | 16.24 | 8.35 |
| Tax % | 24.20% | 25.92% | 25.04% | 25.37% | 25.74% | 25.37% | 27.00% | 25.06% | 25.42% | 25.50% | 27.81% | 25.74% | 30.90% |
| Net Profit | 52.67 | 57.28 | 65.05 | 65.13 | 42.65 | 42.15 | 33.89 | 38.19 | 29.89 | 20.97 | 26.12 | 12.06 | 5.77 |
| EPS in Rs | 6.04 | 6.56 | 7.45 | 7.46 | 4.89 | 4.83 | 3.88 | 4.38 | 3.43 | 2.40 | 2.99 | 1.38 | 0.66 |
Last Updated: December 30, 2025, 5:32 am
Below is a detailed analysis of the quarterly data for Kuantum Papers Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:
- For Sales, as of Sep 2025, the value is 279.70 Cr.. The value appears strong and on an upward trend. It has increased from 222.92 Cr. (Jun 2025) to 279.70 Cr., marking an increase of 56.78 Cr..
- For Expenses, as of Sep 2025, the value is 245.36 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 182.52 Cr. (Jun 2025) to 245.36 Cr., marking an increase of 62.84 Cr..
- For Operating Profit, as of Sep 2025, the value is 34.34 Cr.. The value appears to be declining and may need further review. It has decreased from 40.40 Cr. (Jun 2025) to 34.34 Cr., marking a decrease of 6.06 Cr..
- For OPM %, as of Sep 2025, the value is 12.28%. The value appears to be declining and may need further review. It has decreased from 18.12% (Jun 2025) to 12.28%, marking a decrease of 5.84%.
- For Other Income, as of Sep 2025, the value is 2.21 Cr.. The value appears strong and on an upward trend. It has increased from 1.43 Cr. (Jun 2025) to 2.21 Cr., marking an increase of 0.78 Cr..
- For Interest, as of Sep 2025, the value is 11.90 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 10.39 Cr. (Jun 2025) to 11.90 Cr., marking an increase of 1.51 Cr..
- For Depreciation, as of Sep 2025, the value is 16.30 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 15.20 Cr. (Jun 2025) to 16.30 Cr., marking an increase of 1.10 Cr..
- For Profit before tax, as of Sep 2025, the value is 8.35 Cr.. The value appears to be declining and may need further review. It has decreased from 16.24 Cr. (Jun 2025) to 8.35 Cr., marking a decrease of 7.89 Cr..
- For Tax %, as of Sep 2025, the value is 30.90%. The value appears to be increasing, which may not be favorable. It has increased from 25.74% (Jun 2025) to 30.90%, marking an increase of 5.16%.
- For Net Profit, as of Sep 2025, the value is 5.77 Cr.. The value appears to be declining and may need further review. It has decreased from 12.06 Cr. (Jun 2025) to 5.77 Cr., marking a decrease of 6.29 Cr..
- For EPS in Rs, as of Sep 2025, the value is 0.66. The value appears to be declining and may need further review. It has decreased from 1.38 (Jun 2025) to 0.66, marking a decrease of 0.72.
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
Profit & Loss - Annual Report
Last Updated: December 15, 2025, 5:04 am
| Metric | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 477 | 499 | 526 | 608 | 704 | 793 | 745 | 404 | 830 | 1,310 | 1,211 | 1,107 | 1,050 |
| Expenses | 402 | 435 | 460 | 490 | 556 | 637 | 625 | 374 | 710 | 930 | 860 | 860 | 865 |
| Operating Profit | 76 | 64 | 65 | 118 | 148 | 156 | 119 | 30 | 120 | 380 | 351 | 247 | 185 |
| OPM % | 16% | 13% | 12% | 19% | 21% | 20% | 16% | 7% | 14% | 29% | 29% | 22% | 18% |
| Other Income | 3 | 1 | 1 | 3 | 3 | 9 | 9 | 1 | 4 | -60 | -12 | 3 | 7 |
| Interest | 22 | 21 | 20 | 21 | 25 | 29 | 31 | 28 | 70 | 71 | 44 | 40 | 43 |
| Depreciation | 19 | 13 | 14 | 15 | 19 | 25 | 32 | 35 | 46 | 45 | 48 | 54 | 60 |
| Profit before tax | 37 | 32 | 33 | 84 | 107 | 111 | 65 | -32 | 8 | 203 | 248 | 155 | 89 |
| Tax % | 10% | 21% | 25% | 30% | 32% | 30% | -10% | -60% | -74% | 33% | 26% | 26% | |
| Net Profit | 34 | 25 | 25 | 59 | 73 | 78 | 72 | -13 | 13 | 136 | 184 | 115 | 65 |
| EPS in Rs | 3.84 | 2.87 | 2.81 | 6.79 | 8.35 | 8.93 | 8.23 | -1.46 | 1.54 | 15.60 | 21.07 | 13.20 | 7.43 |
| Dividend Payout % | 0% | 3% | 4% | 3% | 3% | 6% | 3% | 0% | 0% | 19% | 14% | 23% |
YoY Net Profit Growth
| Year | 2014-2015 | 2015-2016 | 2016-2017 | 2017-2018 | 2018-2019 | 2019-2020 | 2020-2021 | 2021-2022 | 2022-2023 | 2023-2024 | 2024-2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| YoY Net Profit Growth (%) | -26.47% | 0.00% | 136.00% | 23.73% | 6.85% | -7.69% | -118.06% | 200.00% | 946.15% | 35.29% | -37.50% |
| Change in YoY Net Profit Growth (%) | 0.00% | 26.47% | 136.00% | -112.27% | -16.88% | -14.54% | -110.36% | 318.06% | 746.15% | -910.86% | -72.79% |
Kuantum Papers Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 11 years from 2014-2015 to 2024-2025.
Growth
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 8% |
| 5 Years: | 8% |
| 3 Years: | 10% |
| TTM: | -11% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 17% |
| 5 Years: | 10% |
| 3 Years: | 105% |
| TTM: | -43% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 30% |
| 5 Years: | 17% |
| 3 Years: | -1% |
| 1 Year: | -24% |
| Return on Equity | |
|---|---|
| 10 Years: | 10% |
| 5 Years: | 11% |
| 3 Years: | 16% |
| Last Year: | 10% |
Last Updated: September 5, 2025, 9:25 am
Balance Sheet
Last Updated: December 10, 2025, 2:59 am
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 9 | 9 | 9 | 9 | 9 | 9 | 9 | 9 | 9 | 9 | 9 | 9 | 9 |
| Reserves | 100 | 532 | 552 | 612 | 683 | 758 | 823 | 809 | 822 | 958 | 1,115 | 1,204 | 1,196 |
| Borrowings | 177 | 224 | 243 | 302 | 321 | 395 | 573 | 689 | 762 | 513 | 512 | 654 | 678 |
| Other Liabilities | 94 | 91 | 100 | 88 | 109 | 123 | 144 | 108 | 83 | 210 | 251 | 246 | 276 |
| Total Liabilities | 379 | 856 | 903 | 1,011 | 1,121 | 1,284 | 1,549 | 1,614 | 1,676 | 1,689 | 1,888 | 2,113 | 2,158 |
| Fixed Assets | 265 | 673 | 687 | 772 | 825 | 978 | 1,034 | 1,436 | 1,408 | 1,414 | 1,475 | 1,619 | 1,741 |
| CWIP | 0 | 26 | 50 | 42 | 84 | 55 | 310 | 21 | 29 | 31 | 42 | 156 | 150 |
| Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Assets | 114 | 157 | 166 | 198 | 213 | 251 | 206 | 158 | 239 | 245 | 371 | 338 | 266 |
| Total Assets | 379 | 856 | 903 | 1,011 | 1,121 | 1,284 | 1,549 | 1,614 | 1,676 | 1,689 | 1,888 | 2,113 | 2,158 |
Below is a detailed analysis of the balance sheet data for Kuantum Papers Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:
- For Equity Capital, as of Sep 2025, the value is 9.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 9.00 Cr..
- For Reserves, as of Sep 2025, the value is 1,196.00 Cr.. The value appears to be declining and may need further review. It has decreased from 1,204.00 Cr. (Mar 2025) to 1,196.00 Cr., marking a decrease of 8.00 Cr..
- For Borrowings, as of Sep 2025, the value is 678.00 Cr.. The value appears to be increasing, which may not be favorable. Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has increased from 654.00 Cr. (Mar 2025) to 678.00 Cr., marking an increase of 24.00 Cr..
- For Other Liabilities, as of Sep 2025, the value is 276.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 246.00 Cr. (Mar 2025) to 276.00 Cr., marking an increase of 30.00 Cr..
- For Total Liabilities, as of Sep 2025, the value is 2,158.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 2,113.00 Cr. (Mar 2025) to 2,158.00 Cr., marking an increase of 45.00 Cr..
- For Fixed Assets, as of Sep 2025, the value is 1,741.00 Cr.. The value appears strong and on an upward trend. It has increased from 1,619.00 Cr. (Mar 2025) to 1,741.00 Cr., marking an increase of 122.00 Cr..
- For CWIP, as of Sep 2025, the value is 150.00 Cr.. The value appears to be declining and may need further review. It has decreased from 156.00 Cr. (Mar 2025) to 150.00 Cr., marking a decrease of 6.00 Cr..
- For Investments, as of Sep 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 0.00 Cr..
- For Other Assets, as of Sep 2025, the value is 266.00 Cr.. The value appears to be declining and may need further review. It has decreased from 338.00 Cr. (Mar 2025) to 266.00 Cr., marking a decrease of 72.00 Cr..
- For Total Assets, as of Sep 2025, the value is 2,158.00 Cr.. The value appears strong and on an upward trend. It has increased from 2,113.00 Cr. (Mar 2025) to 2,158.00 Cr., marking an increase of 45.00 Cr..
Notably, the Reserves (1,196.00 Cr.) exceed the Borrowings (678.00 Cr.), indicating a solid financial buffer.
Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.
Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Free Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | -101.00 | -160.00 | -178.00 | -184.00 | -173.00 | -239.00 | -454.00 | -659.00 | -642.00 | -133.00 | -161.00 | -407.00 |
Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)
Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.
Financial Efficiency Indicators
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 27 | 32 | 25 | 21 | 17 | 15 | 7 | 30 | 27 | 8 | 10 | 13 |
| Inventory Days | 105 | 107 | 102 | 117 | 133 | 95 | 141 | 145 | 114 | 88 | 126 | 141 |
| Days Payable | 89 | 54 | 47 | 47 | 54 | 47 | 42 | 124 | 47 | 25 | 64 | 47 |
| Cash Conversion Cycle | 43 | 85 | 80 | 91 | 95 | 63 | 105 | 51 | 94 | 71 | 73 | 107 |
| Working Capital Days | -33 | -4 | -4 | -6 | -0 | -5 | -19 | -17 | 10 | -4 | -22 | -25 |
| ROCE % | 21% | 10% | 7% | 12% | 14% | 13% | 8% | 0% | 5% | 22% | 20% | 11% |
This stock is not held by any mutual fund.
Key Financial Ratios
| Month | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 |
|---|---|---|---|---|---|
| FaceValue | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 |
| Basic EPS (Rs.) | 13.20 | 21.07 | 15.60 | 1.54 | -1.46 |
| Diluted EPS (Rs.) | 13.20 | 21.07 | 15.60 | 1.54 | -1.46 |
| Cash EPS (Rs.) | 19.39 | 26.59 | 20.81 | 6.83 | 2.53 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 138.97 | 128.79 | 110.79 | 95.17 | 93.65 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 138.97 | 128.79 | 110.79 | 95.17 | 93.65 |
| Dividend / Share (Rs.) | 3.00 | 3.00 | 0.00 | 0.00 | 0.00 |
| Revenue From Operations / Share (Rs.) | 126.86 | 138.81 | 150.07 | 95.16 | 46.28 |
| PBDIT / Share (Rs.) | 28.50 | 38.81 | 43.87 | 14.07 | 4.51 |
| PBIT / Share (Rs.) | 22.31 | 33.28 | 38.66 | 8.78 | 0.51 |
| PBT / Share (Rs.) | 17.81 | 28.37 | 23.26 | 0.88 | -3.65 |
| Net Profit / Share (Rs.) | 13.20 | 21.07 | 15.60 | 1.54 | -1.46 |
| PBDIT Margin (%) | 22.46 | 27.96 | 29.23 | 14.78 | 9.73 |
| PBIT Margin (%) | 17.58 | 23.97 | 25.76 | 9.23 | 1.11 |
| PBT Margin (%) | 14.03 | 20.44 | 15.49 | 0.92 | -7.88 |
| Net Profit Margin (%) | 10.40 | 15.17 | 10.39 | 1.61 | -3.15 |
| Return on Networth / Equity (%) | 9.49 | 16.35 | 14.08 | 1.61 | -1.55 |
| Return on Capital Employeed (%) | 10.90 | 18.31 | 22.78 | 5.10 | 0.30 |
| Return On Assets (%) | 5.45 | 9.73 | 8.05 | 0.80 | -0.78 |
| Long Term Debt / Equity (X) | 0.33 | 0.27 | 0.34 | 0.74 | 0.71 |
| Total Debt / Equity (X) | 0.53 | 0.45 | 0.49 | 0.88 | 0.78 |
| Asset Turnover Ratio (%) | 0.55 | 0.67 | 0.77 | 0.50 | 0.25 |
| Current Ratio (X) | 0.83 | 1.02 | 1.02 | 1.23 | 0.98 |
| Quick Ratio (X) | 0.44 | 0.64 | 0.58 | 0.73 | 0.63 |
| Inventory Turnover Ratio (X) | 9.26 | 3.55 | 4.50 | 4.31 | 1.90 |
| Dividend Payout Ratio (NP) (%) | 22.72 | 14.24 | 0.00 | 0.00 | 0.00 |
| Dividend Payout Ratio (CP) (%) | 15.47 | 11.28 | 0.00 | 0.00 | 0.00 |
| Earning Retention Ratio (%) | 77.28 | 85.76 | 0.00 | 0.00 | 0.00 |
| Cash Earning Retention Ratio (%) | 84.53 | 88.72 | 0.00 | 0.00 | 0.00 |
| Interest Coverage Ratio (X) | 6.33 | 7.90 | 5.39 | 1.78 | 1.42 |
| Interest Coverage Ratio (Post Tax) (X) | 3.93 | 5.29 | 3.81 | 1.19 | 0.85 |
| Enterprise Value (Cr.) | 1512.26 | 1786.29 | 1555.37 | 1448.18 | 1240.79 |
| EV / Net Operating Revenue (X) | 1.37 | 1.47 | 1.19 | 1.74 | 3.07 |
| EV / EBITDA (X) | 6.08 | 5.27 | 4.06 | 11.79 | 31.55 |
| MarketCap / Net Operating Revenue (X) | 0.79 | 1.12 | 0.80 | 0.84 | 1.44 |
| Retention Ratios (%) | 77.27 | 85.75 | 0.00 | 0.00 | 0.00 |
| Price / BV (X) | 0.72 | 1.20 | 1.10 | 0.84 | 0.71 |
| Price / Net Operating Revenue (X) | 0.79 | 1.12 | 0.80 | 0.84 | 1.44 |
| EarningsYield | 0.13 | 0.13 | 0.12 | 0.01 | -0.02 |
After reviewing the key financial ratios for Kuantum Papers Ltd, here is a detailed analysis based on the latest available data and recent trends:
- For FaceValue, as of Mar 25, the value is 1.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 1.00.
- For Basic EPS (Rs.), as of Mar 25, the value is 13.20. This value is within the healthy range. It has decreased from 21.07 (Mar 24) to 13.20, marking a decrease of 7.87.
- For Diluted EPS (Rs.), as of Mar 25, the value is 13.20. This value is within the healthy range. It has decreased from 21.07 (Mar 24) to 13.20, marking a decrease of 7.87.
- For Cash EPS (Rs.), as of Mar 25, the value is 19.39. This value is within the healthy range. It has decreased from 26.59 (Mar 24) to 19.39, marking a decrease of 7.20.
- For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 138.97. It has increased from 128.79 (Mar 24) to 138.97, marking an increase of 10.18.
- For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 138.97. It has increased from 128.79 (Mar 24) to 138.97, marking an increase of 10.18.
- For Dividend / Share (Rs.), as of Mar 25, the value is 3.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 3.00.
- For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 126.86. It has decreased from 138.81 (Mar 24) to 126.86, marking a decrease of 11.95.
- For PBDIT / Share (Rs.), as of Mar 25, the value is 28.50. This value is within the healthy range. It has decreased from 38.81 (Mar 24) to 28.50, marking a decrease of 10.31.
- For PBIT / Share (Rs.), as of Mar 25, the value is 22.31. This value is within the healthy range. It has decreased from 33.28 (Mar 24) to 22.31, marking a decrease of 10.97.
- For PBT / Share (Rs.), as of Mar 25, the value is 17.81. This value is within the healthy range. It has decreased from 28.37 (Mar 24) to 17.81, marking a decrease of 10.56.
- For Net Profit / Share (Rs.), as of Mar 25, the value is 13.20. This value is within the healthy range. It has decreased from 21.07 (Mar 24) to 13.20, marking a decrease of 7.87.
- For PBDIT Margin (%), as of Mar 25, the value is 22.46. This value is within the healthy range. It has decreased from 27.96 (Mar 24) to 22.46, marking a decrease of 5.50.
- For PBIT Margin (%), as of Mar 25, the value is 17.58. This value is within the healthy range. It has decreased from 23.97 (Mar 24) to 17.58, marking a decrease of 6.39.
- For PBT Margin (%), as of Mar 25, the value is 14.03. This value is within the healthy range. It has decreased from 20.44 (Mar 24) to 14.03, marking a decrease of 6.41.
- For Net Profit Margin (%), as of Mar 25, the value is 10.40. This value exceeds the healthy maximum of 10. It has decreased from 15.17 (Mar 24) to 10.40, marking a decrease of 4.77.
- For Return on Networth / Equity (%), as of Mar 25, the value is 9.49. This value is below the healthy minimum of 15. It has decreased from 16.35 (Mar 24) to 9.49, marking a decrease of 6.86.
- For Return on Capital Employeed (%), as of Mar 25, the value is 10.90. This value is within the healthy range. It has decreased from 18.31 (Mar 24) to 10.90, marking a decrease of 7.41.
- For Return On Assets (%), as of Mar 25, the value is 5.45. This value is within the healthy range. It has decreased from 9.73 (Mar 24) to 5.45, marking a decrease of 4.28.
- For Long Term Debt / Equity (X), as of Mar 25, the value is 0.33. This value is within the healthy range. It has increased from 0.27 (Mar 24) to 0.33, marking an increase of 0.06.
- For Total Debt / Equity (X), as of Mar 25, the value is 0.53. This value is within the healthy range. It has increased from 0.45 (Mar 24) to 0.53, marking an increase of 0.08.
- For Asset Turnover Ratio (%), as of Mar 25, the value is 0.55. It has decreased from 0.67 (Mar 24) to 0.55, marking a decrease of 0.12.
- For Current Ratio (X), as of Mar 25, the value is 0.83. This value is below the healthy minimum of 1.5. It has decreased from 1.02 (Mar 24) to 0.83, marking a decrease of 0.19.
- For Quick Ratio (X), as of Mar 25, the value is 0.44. This value is below the healthy minimum of 1. It has decreased from 0.64 (Mar 24) to 0.44, marking a decrease of 0.20.
- For Inventory Turnover Ratio (X), as of Mar 25, the value is 9.26. This value exceeds the healthy maximum of 8. It has increased from 3.55 (Mar 24) to 9.26, marking an increase of 5.71.
- For Dividend Payout Ratio (NP) (%), as of Mar 25, the value is 22.72. This value is within the healthy range. It has increased from 14.24 (Mar 24) to 22.72, marking an increase of 8.48.
- For Dividend Payout Ratio (CP) (%), as of Mar 25, the value is 15.47. This value is below the healthy minimum of 20. It has increased from 11.28 (Mar 24) to 15.47, marking an increase of 4.19.
- For Earning Retention Ratio (%), as of Mar 25, the value is 77.28. This value exceeds the healthy maximum of 70. It has decreased from 85.76 (Mar 24) to 77.28, marking a decrease of 8.48.
- For Cash Earning Retention Ratio (%), as of Mar 25, the value is 84.53. This value exceeds the healthy maximum of 70. It has decreased from 88.72 (Mar 24) to 84.53, marking a decrease of 4.19.
- For Interest Coverage Ratio (X), as of Mar 25, the value is 6.33. This value is within the healthy range. It has decreased from 7.90 (Mar 24) to 6.33, marking a decrease of 1.57.
- For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 3.93. This value is within the healthy range. It has decreased from 5.29 (Mar 24) to 3.93, marking a decrease of 1.36.
- For Enterprise Value (Cr.), as of Mar 25, the value is 1,512.26. It has decreased from 1,786.29 (Mar 24) to 1,512.26, marking a decrease of 274.03.
- For EV / Net Operating Revenue (X), as of Mar 25, the value is 1.37. This value is within the healthy range. It has decreased from 1.47 (Mar 24) to 1.37, marking a decrease of 0.10.
- For EV / EBITDA (X), as of Mar 25, the value is 6.08. This value is within the healthy range. It has increased from 5.27 (Mar 24) to 6.08, marking an increase of 0.81.
- For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 0.79. This value is below the healthy minimum of 1. It has decreased from 1.12 (Mar 24) to 0.79, marking a decrease of 0.33.
- For Retention Ratios (%), as of Mar 25, the value is 77.27. This value exceeds the healthy maximum of 70. It has decreased from 85.75 (Mar 24) to 77.27, marking a decrease of 8.48.
- For Price / BV (X), as of Mar 25, the value is 0.72. This value is below the healthy minimum of 1. It has decreased from 1.20 (Mar 24) to 0.72, marking a decrease of 0.48.
- For Price / Net Operating Revenue (X), as of Mar 25, the value is 0.79. This value is below the healthy minimum of 1. It has decreased from 1.12 (Mar 24) to 0.79, marking a decrease of 0.33.
- For EarningsYield, as of Mar 25, the value is 0.13. This value is below the healthy minimum of 5. There is no change compared to the previous period (Mar 24) which recorded 0.13.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
Strength and Weakness
| Strength | Weakness |
|---|---|
|
|
Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Kuantum Papers Ltd:
- Net Profit Margin: 10.4%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
- ROCE: 10.9% (Industry Average ROCE: 9.32%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
- ROE%: 9.49% (Industry Average ROE: 134.8%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
- Interest Coverage Ratio (Post Tax): 3.93
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
- Quick Ratio: 0.44
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
- Stock P/E: 11.6 (Industry average Stock P/E: 43.19)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
- Total Debt / Equity: 0.53
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
Stock Rating: - Net Profit Margin: 10.4%
About the Company - Qualitative Analysis
| INDUSTRY | ADDRESS | CONTACT |
|---|---|---|
| Paper & Paper Products | Paper Mill, Sailakhurd Punjab 144529 | Contact not found |
| Management | |
|---|---|
| Name | Position Held |
| Mr. Jagesh Kumar Khaitan | Chairman |
| Mr. Pavan Khaitan | Vice Chairman & Mng.Director |
| Mr. Munishwar Kumar | Non Executive Director |
| Mr. Vivek Bihani | Independent Director |
| Mr. Shireen Sethi | Independent Director |
| Mr. Bhavdeep Sardana | Independent Director |
FAQ
What is the intrinsic value of Kuantum Papers Ltd?
Kuantum Papers Ltd's intrinsic value (as of 29 January 2026) is ₹183.36 which is 113.21% higher the current market price of ₹86.00, indicating undervalued. Calculated using the PE ratio method, this valuation considers the company's ₹754 Cr. market cap, FY2025-2026 high/low of ₹135/84.2, reserves of ₹1,196 Cr, and liabilities of ₹2,158 Cr.
What is the Market Cap of Kuantum Papers Ltd?
The Market Cap of Kuantum Papers Ltd is 754 Cr..
What is the current Stock Price of Kuantum Papers Ltd as on 29 January 2026?
The current stock price of Kuantum Papers Ltd as on 29 January 2026 is ₹86.0.
What is the High / Low of Kuantum Papers Ltd stocks in FY 2025-2026?
In FY 2025-2026, the High / Low of Kuantum Papers Ltd stocks is ₹135/84.2.
What is the Stock P/E of Kuantum Papers Ltd?
The Stock P/E of Kuantum Papers Ltd is 11.6.
What is the Book Value of Kuantum Papers Ltd?
The Book Value of Kuantum Papers Ltd is 138.
What is the Dividend Yield of Kuantum Papers Ltd?
The Dividend Yield of Kuantum Papers Ltd is 3.48 %.
What is the ROCE of Kuantum Papers Ltd?
The ROCE of Kuantum Papers Ltd is 11.4 %.
What is the ROE of Kuantum Papers Ltd?
The ROE of Kuantum Papers Ltd is 10.1 %.
What is the Face Value of Kuantum Papers Ltd?
The Face Value of Kuantum Papers Ltd is 1.00.